Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Publications

Protective early innate immune activation by mitochondrial antiviral signalling protein (MAVS) in bacterial pneumonia

Hinks T. et al, (2025)

Inflammatory and clinical prognostic factors for asthma attacks: a patient-level meta-analysis of control arms of 22 randomised trials

Meulmeester FL. et al, (2025), The Lancet Respiratory Medicine

MAIT cells protect against sterile lung injury

Zhang X. et al, (2025), Cell Reports

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment.

Lavoie G. et al, (2024), Thorax

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment

Lavoie G. et al, (2024), Thorax

Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma

HINKS T., (2024), Journal of Allergy and Clinical Immunology

Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma

JABEEN M. et al, (2024), Allergy

The effects of inhaled corticosteroids on healthy airways

MARCHI E. et al, (2024), Allergy

Anti-inflammatory effects of oral prednisolone at stable state in people treated with mepolizumab: a proteomic and bulk transcriptomics analysis

Howell I. et al, (2024)

MAIT cells protect against sterile lung injury

Zhang X. et al, (2024)

The effects of inhaled corticosteroids on healthy airways

Marchi E. et al, (2023)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)

Howell I. et al, (2023), JMIR Research Protocols, 12, e46741 - e46741

An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.

Wing PAC. et al, (2023), PLoS Pathog, 19

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST) (Preprint)

Howell I. et al, (2023)

MAIT cells and the microbiome

JABEEN MF. and HINKS TSC., (2023), Frontiers in Immunology

Editorial: MAIT cells come of age

Corbett AJ. et al, (2023), Frontiers in Immunology, 14

Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae.

Brown MA. et al, (2023), Front Cell Infect Microbiol, 13

Healthy volunteer symptom profile following research bronchoscopy

Morrison H. et al, (2023), EUROPEAN RESPIRATORY JOURNAL, 62

BIO-AST Biologics for chronic severe asthma: a network meta-analysis

Crossingham I. et al, (2022), Cochrane Database of Systematic Reviews, 2022

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?

HINKS T. et al, (2022), European Respiratory Review

Load More